Histopathologic analysis revealed a malignant B-cell lymphoma with a MYC gene rearrangement in the absence of BCL2 or BCL6 rearrangements, consistent with a high-grade lymphoma (Figure 4). This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.